GlassScriptPhysician profile
Sara Bess Baumrind
NPI 1831398866
$2,565.14
in general payments reported to CMS, 2019-2025
13 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2021: $677 · 2022: $1,254 · 2023: $110 · 2024: $111 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281 · Gift: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.50 |
| Gift | $128.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,213.23 | 2021-2024 | Cavitron, Suresmile |
| A-Dec, INC. | $371.00 | 2021 | |
| Zimvie INC. | $266.55 | 2022-2025 | |
| Nobel Biocare USA | $154.01 | 2019 | |
| Ultradent Products INC | $128.49 | 2025 | Opalescence |
| Henry Schein, INC. | $94.58 | 2021-2023 | |
| Straumann USA LLC | $93.75 | 2022 | |
| Kerr Corporation | $90.85 | 2021 | |
| Tulsa Dental Products LLC | $70.70 | 2019 | |
| Thommen Medical USA, LLC | $40.02 | 2024 | |
| Solventum Corporation | $16.99 | 2025 | Clarity Aligners |
| Orapharma, A Division of Bausch Health US, LLC | $14.33 | 2024 | Ossix Plus, Arestin |
| Colgate Oral Pharmaceuticals, INC. | $10.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Baumrind listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.